Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 24
Healthy volunteers: yes

Brief summary:
Participants in this study will receive 3 single oral doses of LY2835219 at least 14 days apart. One dose will be given with a standard meal, one dose with a high-fat meal and one dose without food. The study will evaluate the effects of the standard and high-fat meals on how much drug gets into the bloodstream. Side effects will be documented. This study is approximately 43 days, not including screening. Screening is required within 28 days prior to the start of the study.

Detailed description:

Arms:
arm 1: Single oral dose of LY2835219 given with a standard meal in one of three study periods. arm 2: Single oral dose of LY2835219 given with no food in one of three periods. arm 3: Single oral dose of LY2835219 given with a high fat meal in one of three periods.

Interventions: intervention 1: LY2835219
Intervention descriptions: intervention 1: Administered orally.

Protocol document: